ORAVEXX Trademark

Trademark Overview

On Tuesday, December 8, 2020, a trademark application was filed for ORAVEXX with the United States Patent and Trademark Office. The USPTO has given the ORAVEXX trademark a serial number of 90366516. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2024. This trademark is owned by Orcosa Inc.. The ORAVEXX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for acute and chronic pain management and the treatment of cancer
oravexx

General Information

Serial Number90366516
Word MarkORAVEXX
Filing DateTuesday, December 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for acute and chronic pain management and the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrcosa Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameOrcosa Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628

Trademark Events

Event DateEvent Description
Friday, December 11, 2020NEW APPLICATION ENTERED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Monday, June 7, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, June 7, 2021EXAMINERS AMENDMENT E-MAILED
Monday, June 7, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 7, 2021EXAMINER'S AMENDMENT ENTERED
Monday, June 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 7, 2022SOU EXTENSION 1 FILED
Tuesday, April 12, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 12, 2022PETITION TO REVIVE-GRANTED
Tuesday, April 12, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 12, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, May 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 13, 2022SOU EXTENSION 1 GRANTED
Saturday, May 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022SOU EXTENSION 2 FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, October 11, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 11, 2022PETITION TO REVIVE-GRANTED
Tuesday, October 11, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 11, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, October 13, 2022SOU EXTENSION 2 GRANTED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, April 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, April 20, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, April 24, 2023SOU EXTENSION 3 GRANTED
Tuesday, March 7, 2023SOU EXTENSION 3 FILED
Thursday, April 20, 2023PETITION TO REVIVE-GRANTED
Thursday, April 20, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, April 21, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2023SOU EXTENSION 4 FILED
Monday, October 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, December 4, 2023PETITION TO REVIVE-GRANTED
Monday, December 4, 2023NOTICE OF REVIVAL - E-MAILED
Monday, December 4, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, December 4, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 4 GRANTED
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, May 1, 2024PETITION TO REVIVE-GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2024SOU EXTENSION 5 FILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 1, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, May 1, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, May 1, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, May 1, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, May 3, 2024SOU EXTENSION 5 GRANTED
Monday, October 14, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 14, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

oravexx management treatment cancer pain chronic preparations acute pharmaceutical